1. U.S. Department of Health and Human Services FDA. Guidance for Industry - PAT A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance. 2004;1–19.
2. Fontalvo-Lascano MA, Méndez-Piñero MI, Romañach RJ. Development of a business case model for process analytical technology implementation in the pharmaceutical industry. Proceedings of the 5th NA International Conference on Industrial Engineering and Operations Management. Detroit, Michigan: IEOM Society International. 2020;1144–52.
3. Qaid WAA, Finaev VI, Tychinsky AV. Algorithmization of the process of preparation of capital investment project. Mediterr J Soc Sci. 2015;6(2):354.
4. Maes I, Van Liedekerke B. The need for a broader perspective if process analytical technology implementation is to be successful in the pharmaceutical sector. J Pharm Innov. 2006;1(1):19–21.
5. Kourti T, Davis B. The business benefits of quality by design (QbD). Pharm Eng. 2012;32(4):1–10.